Ability of measures of adiposity in identifying adverse levels of inflammatory and metabolic markers in adolescents by Oliveira-Santos, J et al.
University of Wollongong 
Research Online 
Faculty of Social Sciences - Papers Faculty of Arts, Social Sciences & Humanities 
1-1-2016 
Ability of measures of adiposity in identifying adverse levels of 
inflammatory and metabolic markers in adolescents 
J Oliveira-Santos 
University of Porto 
Rute Santos 
University of Wollongong, rutes@uow.edu.au 
Carla Moreira 
University of Porto 
Sandra Abreu 
University of Porto 
Luis Lopes 
University of Porto 
See next page for additional authors 
Follow this and additional works at: https://ro.uow.edu.au/sspapers 
 Part of the Education Commons, and the Social and Behavioral Sciences Commons 
Recommended Citation 
Oliveira-Santos, J; Santos, Rute; Moreira, Carla; Abreu, Sandra; Lopes, Luis; Agostinis-Sobrinho, C; and 
Mota, Jorge, "Ability of measures of adiposity in identifying adverse levels of inflammatory and metabolic 
markers in adolescents" (2016). Faculty of Social Sciences - Papers. 2166. 
https://ro.uow.edu.au/sspapers/2166 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Ability of measures of adiposity in identifying adverse levels of inflammatory and 
metabolic markers in adolescents 
Abstract 
Background: Overweight and obesity have been associated with a pro-inflammatory state. We aimed to 
assess the ability of different measures of overall and abdominal adiposity for identifying adverse levels 
of inflammatory and metabolic markers in adolescents. Methods: This is a cross-sectional analysis with 
529 Portuguese adolescents (267 girls), mean age 14.3 ± 1.7 years. Weight, height, sitting height, waist 
circumference (WC), and body fat percentage (BF%) were measured; and BMI, waist-to-height ratio 
(WHtR), and waist-to-sitting-height ratio (WsHtR) were calculated. We measured C-reactive protein (CRP), 
fibrinogen, erythrocyte sedimentation rate (ESR), complements C3 and C4, leptin, and adiponectin levels. 
Receiver operating characteristic (ROC) curves were used to estimate the ability of the adiposity 
measures to discriminate between low/high values of biomarkers. Results: The highest areas under the 
ROC curves were presented by BF% for fibrinogen and complement C3 in both sexes and for ESR, 
complement C4, and adiponectin only in girls; by BMI for CRP in girls and for leptin in both sexes; by WHtR 
for leptin in both sexes and for CRP, fibrinogen, and adiponectin only in girls; by waist circumference for 
CRP, fibrinogen, and complement C3 only in boys and for complement C4 in girls; and by WsHtR for 
complement C3 in girls; p < 0.05 for all. Conclusions: The measures that more often presented 
discriminatory power were, for overall adiposity, BF% in both sexes, and for abdominal adiposity, WHtR in 
girls and WC in boys. However, small differences in discriminatory capabilities don't allow us to clearly 
defend the adoption of a single measure above all others. 
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BACKGROUND: Overweight and obesity have been associated with a pro-inflammatory 
state. We aimed to assess the ability of different measures of overall and abdominal adiposity 
in identifying adverse levels of inflammatory and metabolic markers in adolescents. 
METHODS: This is a cross-sectional analysis with 529 Portuguese adolescents (267 girls), 
mean age 14.3±1.7 years. Weight, height, sitting height, waist circumference and body fat 
percentage (BF%) were measured, and body mass index (BMI), waist-to-height ratio (WHtR) 
and waist-to-sitting-height ratio (WsHtR) were calculated. We measured C-reactive protein 
(CRP), fibrinogen, erythrocyte sedimentation rate (ESR), complements C3 and C4, leptin and 
adiponectin levels. Receiver operating characteristic (ROC) curves were used to estimate the 
ability of the adiposity measures to discriminate between low/high values of biomarkers. 
RESULTS: The highest areas under the ROC curves were presented by: BF% for fibrinogen 
and complement C3, in both sexes, and for ESR, complement C4 and adiponectin, only in 
girls; BMI for CRP in girls, and for leptin in both sexes; WHtR for leptin in both sexes, and for 
CRP, fibrinogen and adiponectin, only in girls; waist circumference for CRP, fibrinogen and 
complement C3, only in boys, and for complement C4, in girls; WsHtR for complement C3, in 
girls. p<0.05 for all. 
CONCLUSIONS: The measures that more often presented discriminatory power were, for 
overall adiposity, BF% in both sexes, and for abdominal adiposity, WHtR in girls and WC in 
boys. However, small differences in discriminatory capabilities don’t allow us to clearly defend 
the adoption of a single measure above all others. 
 
 








Overweight and obesity have been associated with a condition of chronic low-grade 
systemic inflammation even in children1,2 and adolescents3,4, with evidence of tracking into 
adulthood,5,6 contributing to an increased risk of cardiovascular disorders and diabetes7 over 
time. 
Several anthropometrical measures, indices and techniques have been used in 
epidemiological studies to assess obesity in youngsters, as alternatives to more accurate but 
hardly feasible laboratory assessment, because of the constraints in time, sample 
mobilization and high costs.8 Although body mass index (BMI) is probably the most widely 
used index to define weight status across populations,9,10 other techniques also provide 
information on overall adiposity, such as bioelectric impedance and skinfold measurements, 
with estimates of body fat percentage (BF%). 
In addition, other anthropometric measures have focused on abdominal obesity, a 
known independent risk factor for insulin resistance and cardiovascular diseases in children 
and adolescents.11,12 Low-grade systemic inflammation in youth has been shown to be 
associated with high waist circumference (WC),13 waist-to-hip ratio (WHR)14 and waist-to-
height ratio (WHtR).15 Moreover, individuals with a greater percentage of visceral fat appear 
to have higher levels of some circulating cytokines and acute-phase reactants than individuals 
with a higher percentage of subcutaneous fat,16  suggesting that visceral fat could play a more 
active role in the development of systemic inflammation. 
Therefore, the search for one anthropometric measure (or more) that may adequately 
provide sensitivity and specificity to reflect not only adiposity, but also an adverse 
inflammatory condition, seems pertinent. 
In light of the heterogeneity and lack of previous studies, we aimed to examine and 
compare different measures of overall obesity such as BMI and BF%, and central obesity like 
WC, WHtR and waist-to-sitting-height ratio (WsHtR), with respect to their ability to detect 
increased levels of inflammatory and metabolic markers in a sample of Portuguese 




SUBJECTS, MATERIALS AND METHODS 
Study design and sampling 
We used baseline data from the Longitudinal Analysis of Biomarkers and 
Environmental Determinants of Physical Activity Study (LabMed Physical Activity Study), a 
school-based prospective cohort study carried out in five schools from the north of Portugal, 
which aimed to evaluate the independent and combined associations of dietary intake and 
fitness levels on blood pressure levels of adolescents. The power calculation for that study 
was based on the exposure of combined healthy diet/physical activity pattern with a 
prevalence of 14%.17 A sample of 754 participants would provide 80% power to detect 15% 
difference between exposed and unexposed at 5% significance, but taking into account an 
expected dropout rate of about 20% at each time-point, the minimum sample size was 
increased to 1086. Baseline data was collected in the fall of 2011, for all pupils that agreed to 
participate in the study (n=1229). From this initial total sample of apparently healthy 
adolescents (12–18 years old), 534 agreed to undergo blood collection. Five of them were 
later excluded from the analysis due to high sensitivity C-reactive protein (CRP) values 
>10mg/L, which may be indicative of acute inflammation or illness,18 leaving 529 adolescents 
(267 girls, 262 boys, mean age 14.3±1.7 years) as the final sample for the present study. This 
number fulfills the condition of a Receiver Operating Characteristic (ROC) sample size 
calculation (providing 80% power at 5% significance, for a minimum expected AUC of 0.6 and 
null hypothesis value of 0.5) requiring at least 514 subjects for the present study. 
This study was conducted in accordance with the Helsinki Declaration for Human 
Studies of 1975, as revised in 2008, and approved by the Portuguese Data Protection 
Authority (#1112434/2011) and the Portuguese Ministry of Science and Education 
(0246200001/2011). All participants were informed of the study’s goals and all procedures 
were carried out with the adequate understanding of the subjects, and written informed 
consent was obtained from participating adolescents and their parents/tutors. 
 
Anthropometric measurements 
Anthropometric measurements were performed according to standardized 
procedures,19 with all participants lightly dressed with a t-shirt, shorts and barefoot. 
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Body weight was measured to the nearest 0.1 kg, using a portable electronic weight 
scale (Tanita InnerScan BC532, Tokyo, Japan). Body height was measured to the nearest 0.1 
cm, with the adolescent standing upright against a portable stadiometer (Seca213, Hamburg, 
Germany). BMI was calculated as weight divided to height squared (kg/m2) and the 
participants were classified as underweight, normal weight, overweight or obese using the 
age and sex-specific cut-off values proposed by the International Obesity Task Force.9,20  
Waist circumference was taken in a standing position, midway between the lower rib 
margin and the anterior superior iliac spine, at the end of a normal expiration, to the nearest 
0.1 cm with a non-elastic tape measure. WHtR was calculated as the WC divided by height, 
both measured in centimetres. 
Sitting height was measured with the participant seated on a table, with back and 
buttocks positioned against a stadiometer and with the head positioned in a Frankfort 
horizontal plane. The participant’s knees were directed straight ahead, with the arms and 
hands resting at the sides. Sitting height was measured from the tabletop to the vertex and 
recorded to the nearest 0.1 cm. WsHtR was also calculated as the WC divided by sitting 
height. 
BF% was measured by bioelectrical impedance21 (Tanita InnerScan BC532) 
according to manufacturer's instructions, in the morning after an overnight fast for at least 10 
hours, and 2 hours after last water intake and urination. Participants were asked not to 
perform any physical exercise before the measurements that morning. The device used is 
suitable for measuring body fat percentage in an age range from 7 to 99 years old according 
the instruction manual, and has already been used for the same purpose in other studies with 
adolescents.22 
 
Pubertal stage assessment 
Pubertal stage (breast and pubic hair development in girls and genital and pubic hair 
development in boys, with stage 1 being pre-pubertal and 5 being adult) was self-assessed by 
the participants according to the classification by Tanner,23 in a private place, and then 




After an overnight fast (>10 hours), blood samples were collected between 8:00–
10:00 a.m. by venipuncture from the antecubital vein. The samples were stored in sterile 
blood collection tubes in refrigerated conditions (4° to 8°C) for no longer than 4 hours during 
the morning of collection, and then delivered to an analytical laboratory for testing according 
to standardized procedures, as follows: (i) high sensitivity CRP, latex enhanced 
immunoturbidimetric assay (Siemens ADVIA 1800, Erlangen, Germany); (ii) fibrinogen, 
Clauss assay (Siemens BCS XP System, Erlangen, Germany); (iii) adiponectin and leptin, 
ELISA (Plate Reader); (iv) complement factor C3 (C3) and complement factor C4 (C4), PEG 
enhanced immunoturbidimetric assay (Siemens ADVIA 1800, Erlangen, Germany); (v) 
erythrocyte sedimentation rate (ESR), Westergren method (Starrsed, RR Mechanotronics, 
Netherlands). CRP, C3, C4, adiponectin and leptin were determined in serum, fibrinogen was 
determined in plasma and ESR was determined in whole blood. The existing literature shows 
that all the biomarkers analyzed in this study have been increasingly explored in studies 




Two-sided Student’s t-Test was used for comparisons between groups. 
For each biomarker, a Z-score was computed by age and sex, and increased levels 
were considered when the individual had ≥1 SD of the Z-score, except for adiponectin, where 
decreased levels were considered when the individual had ≤ -1 SD of the Z-Score. The 
setting of ≥1SD (and ≤-1SD in the case of adiponectin) allowed us to identify the adolescents 
of our sample with the highest values for each biomarker (or lowest, in the case of 
adiponectin), showing two statistically different groups in relation to the biomarkers mean 
values (data not shown), and consequently create two categories for the ROC curves 
analysis. 
ROC curves analyzed the ability of different measures of adiposity to discriminate 
between low/high values of inflammatory and metabolic markers, providing the best trade-off 
between sensitivity and specificity of each adiposity measure and respective cut-off value. 
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The area under the curve (AUC), ranging between 0 and 1 (a worthless and a perfect test, 
respectively), represents the ability of the test to correctly classify the participants with high or 
low inflammatory markers. ROC curve analysis showed which measures of adiposity 
performed well in identifying increased levels of inflammatory and metabolic markers. When 
the AUC >0.5 and p<0.05 was considered that the ROC performed well. Cut-off points were 
chosen based in the highest Youden index. 
Data were analysed using the Statistical Package for Social Sciences version 22.0 
(SPSS, IBM Corp., NY, USA), and MedCalc statistical software version 15 (MedCalc 
software, Mariakerke, Belgium) was used for all the ROC curves analyses, including the 
sample size calculation for this study. A p-value <0.05 denoted statistical significance. 
 
RESULTS 
Participants’ characteristics are shown in Table 1. Boys were heavier, taller, and had 
higher WC than girls, while girls presented higher values of BF% than boys (p<0.05 for all). In 
relation to the biomarkers, only CRP values were higher in boys, whereas fibrinogen, 
adiponectin, erythrocyte sedimentation rate and leptin were higher in girls (p<0.05 for all). 
INSERT TABLE 1 
Tables 2 and 3 presents ROC analysis for the associations of measures of overall 
(BMI and BF%) and abdominal obesity (WC, WHtR and WsHtR) with biomarkers for girls and 
boys, respectively. Values in bold represent the ROC curves indicating the adiposity 
measures that presented the highest AUC for each biomarker. 
BF% was the measure of overall adiposity that more often presented the best 
discriminatory power for both sexes. Higher levels of fibrinogen were suggested by BF% cut-
off values >27.3% for girls and >18.3% for boys, and of C3 by BF% cut-off values >30.7% in 
girls and >18.2% in boys. BF% also showed discriminatory power for high levels of ESR and 
C4 and lower levels of adiponectin, but only for girls. BMI presented the best trade-off 
between sensitivity and specificity for leptin in girls and boys, and for CRP in girls. 
Regarding abdominal adiposity, WC presented the best discriminatory power for 
higher levels of CRP, fibrinogen, and C3 in boys, and for C4 in girls. WHtR showed the best 
trade-off between sensitivity and specificity for detecting in girls increased levels of CRP, 
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fibrinogen and adiponectin, and higher levels of leptin in both girls and boys. WsHtR only 
demonstrated the best discriminatory power for C3 in girls. 
INSERT TABLES 2 AND 3 
 
DISCUSSION 
The main findings of this study showed that for measures of overall adiposity, the 
highest AUC were presented by BF% for fibrinogen and complement C3, in both sexes, and 
for ESR, complement C4 and adiponectin, only in girls; and by BMI for CRP in girls, and for 
leptin in both sexes. Regarding measures of abdominal adiposity, the highest AUC were 
presented by WHtR for leptin in both sexes, and for CRP, fibrinogen and adiponectin, only in 
girls; by WC for CRP, fibrinogen and complement C3, for boys, and for complement C4, in 
girls; and by WsHtR for complement C3, in girls. 
Some studies suggested associations between measures of overall2,3 and 
abdominal28,29 obesity and a series of inflammatory and metabolic markers. However, to the 
best of our knowledge, there is currently no agreement about which anthropometric measures 
predict best adverse levels of inflammatory markers, and how they differ by sex.  
Our results suggest that measures of overall adiposity tended to more often present 
higher AUC in girls, whereas in boys higher AUC were more frequent in measures of 
abdominal obesity. 
Regardless of sex, BF% showed marginally higher differences in the AUC for most of 
the inflammatory markers compared with BMI. BF% coincided for boys and girls as the 
measure of overall adiposity that best predicts increased levels of fibrinogen and C3, with 
slightly higher pooled AUC observed in girls compared to boys, suggesting that discrimination 
is more precise, on average, in girls. For CRP, ESR, C4 and adiponectin, BF% only showed 
discriminatory power for girls. 
BMI was the best measure of overall adiposity for both sexes predicting higher levels 
of leptin, but showing this time an inverse trend, with a higher AUC for boys. In agreement 
with other studies,30,31 we found that leptin and adiponectin levels were significantly lower in 
boys than in girls. It is hypothesized that the increase in testosterone level during male 
puberty could play an important role in the drop of the expression of these adipokines,32 and 
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boys from our study were mainly in pubertal stages 4 and 5. 
BMI also presented a slightly higher AUC than BF% predicting CRP, but this time in 
girls. Analysis of the data from the National Health and Nutrition Examination Survey 
(NHANES)3,33,34 suggests that BMI is a good predictor of elevated CRP in children, and has 
been widely used to predict body composition and health-related risks.9,10 Indeed, in a recent 
systematic review and meta-analysis35 the random-effects summary correlation between BMI 
and CRP in children and adolescents was strong (r=0.37; 95% CI=0.31–0.43). 
Nevertheless, it is important to emphasize that BMI is a measure of excess weight 
relative to height, and does not provide information on the distribution of body fat nor 
differentiates between fat and lean mass.36 In this study we could observe that for a similar 
BMI value for age, girls and boys are different in relation to body composition, indicated by a 
significant higher BF% in girls. In a 7.5-year longitudinal study, Wen et al.6 showed that 
increases in fat mass explained the increases in CRP levels during pubertal growth of Finnish 
girls but not vice versa. 
BF% was the only adiposity measure that showed discriminatory power for all the 
biomarkers in girls, but it should also be noted that, albeit BMI has presented marginally 
inferior AUC than BF% for the rest of the biomarkers (except for CRP in girls and leptin for 
both sexes), still showed discriminatory power for most of them, and these differences from 
BF% were not statistically significant. 
Concerning the predictive power of the measures of abdominal adiposity we 
observed different trends. In girls, WHtR presented the highest AUC for most of the 
biomarkers, while for boys WC was the measure that more often provided better 
discriminatory power. We choose to include and test WsHtR due to its novel character and 
potential usefulness for screening obesity and related health risk,37 but it only presented the 
higher AUC when compared with the other abdominal adiposity measures for C3, in girls. 
Some authors38,39 argue that measures of abdominal adiposity might be more useful 
predictors of cardiometabolic risk in non-obese adolescents, once excess abdominal adiposity 
could be missed if using a whole body measure such as BMI. There may also exist 
differences between sexes as Cartier et al.40 highlighted, although in adults, that CRP 
concentrations seem to be influenced to a greater extent by visceral adiposity in men, as 
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opposed to subcutaneous adiposity in women.  
In a study with healthy Spanish adolescents,41 the authors showed that although BMI 
and WC are strongly correlated and that both measures were good predictors of fat content in 
children and adolescents, they also report that different biomarkers associated with different 
adiposity measures. In that study C3, unlike CRP, C4 and ceruloplasmin, was preferentially 
associated with WC than BMI in both sexes after further adjustments for age, and pubertal 
maturity. 
In another study, composed exclusively by German male adolescents,42 WHtR 
presented a higher AUC for CRP than WC and WHR. In our study, WC was the measure of 
central adiposity that provided better discriminatory power for detecting CRP in boys. We 
observed similar results to Jung et al.42 only in girls. 
According to Taylor et al.,39 youths have the WC equivalent of adult abdominal 
obesity at percentiles lower than the frequently used pediatric threshold of 90%. Besides, the 
WC cut-off values for pediatric ages have to be age and sex specific, so, a fixed cut-off point 
for WC not taking account of height might underestimate the relative amount of abdominal fat 
in short subjects and overestimate it in tall subjects. Likewise, some authors43-45 adjusted the 
WC to the person’s height, proposing the WHtR as a way of assessing shape and monitoring 
risk reduction, first in adults, suggesting that values greater than 0.5 were indicative of 
increased health risks for both sexes, and showing then to be also valid to screen youth as 
young as five years old,46-48 making it interestingly age and sex independent. Systematic 
reviews and meta-analysis49-51 have been suggesting some superiority of WHtR over WC and 
BMI for detecting cardiometabolic risk factors in adults and children of both sexes, of various 
nationalities and ethnic groups. 
In our study, although boys had higher values of WC it probably does not reflect 
larger intra-abdominal fat depots, because when the height of the subjects is considered, we 
observe that they are also significantly taller than girls, in a proportion that seems to correct 
this apparently abdominal obesity in boys. Indeed, there were no differences between sexes 
in the mean values of WHtR and WsHtR. In addition, the mean values of WC of the 
participants of both sexes are placed between the 50th and the 75th percentiles of Portuguese 
adolescents reference data.52 
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The cut-off points range for WHtR suggested by the ROC analysis in our study to 
predict increased levels of inflammatory markers in girls (0.44–0.48) and in boys (0.48–0.49) 
are slightly below the international proposed cut-off value of ≥0.5 that is frequently associated 
with greater risks of overweight and metabolic syndrome, suggesting that even slightly below 
this threshold, some adolescents could present increased levels of some biomarkers. These 
are in line with other studies53,54 suggesting that a WHtR below 0.5 could predict adverse 
outcomes in youths. Nevertheless, further research focusing this thematic on pediatric ages is 
needed to confirm or contrast our findings. 
 
The present study is not without limitations. First, its cross-sectional design does not 
allow us to assess the directionality of the relationships between the different adiposity 
measures and the different biomarkers; second, the use of a single measure of each 
biomarker may not accurately reflect a long-term inflammatory pattern of that specific 
biomarker; last, our sample is not nationally representative, and therefore these results 
cannot be extended to the entire population of Portuguese adolescents. 
The strengths of this study include the analysis of various biomarkers, which provided 
us with a more accurate assessment of the inflammatory status of the adolescents, since we 
rely not only on a single marker; the utilization of various, simple, inexpensive and widespread 
measures of adiposity; the associations between those measures and several biomarkers 
should be further explored in the future, as they could be seen as indirect indicators of the 
inflammation profile of a sample of adolescents, particularly in epidemiological studies, when 
a large number of individuals are assessed and when blood samples may not be taken. 
 
In conclusion, our results highlight the ability and utility of several anthropometric 
measures of overall and abdominal adiposity in detecting increased levels of biomarkers in 
adolescents. The measures that more often presented discriminatory power were, for overall 
adiposity, BF% for both sexes, and in relation to abdominal adiposity, WHtR in girls and WC 
in boys. However, the small differences in the discriminatory capabilities between adiposity 
measures are perhaps of limited relevance, and based on our data it is difficult to clearly 
defend the adoption of a single measure of obesity in preference to all others.  
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Table 1. Anthropometric, biochemical and maturational characteristics of the participants. 
 All (n = 529) Girls  (n = 267) Boys (n = 262) 
Variables Mean ± SD Mean ± SD Mean ± SD 
Age (years) 14.3 ± 1.7 14.3 ± 1.7 14.4 ± 1.7 
Height (cm) 160.3 ± 9.6 157.7 ± 6.7 162.9 ± 11.3 * 
Weight (kg) 55.2 ± 12.8 53.4 ± 11.2 56.9 ± 14.1 * 
BMI (kg/m2) IOTF 21.31 ± 3.84 21.41 ± 3.96 21.20 ± 3.73 
UW/ NW/ OW/ OB (n) 24/ 357/ 111/ 37 10/ 181/ 54/ 22 14/ 176/ 57/ 15 
UW/ NW/ OW/ OB (%) 4.5%/ 67.5%/ 21%/ 7% 3.7% / 67.8%/ 20.3%/ 8.2% 5.3%/ 67.2%/ 21.8%/ 5.7% 
BF% 20.7 ± 8.3 25.4 ± 7.0 15.9 ± 6.7 * 
WC (cm) 73.1 ± 10.2 72 ± 10.2 74.2± 10.2 * 
WHtR 0.45 ± 0.06 0.45 ± 0.6 0.46 ± 0.6 
WsHtR 0.86 ± 0.11 0.86 ± 0.12 0.87 ± 0.1 
CRP (mg/L) 0.95 ± 1.88 0.77 ± 1.59 1.13 ± 2.12 * 
Fibrinogen (mg/dL) 264 ± 43.2 268.13 ± 41.72 259.77 ± 44.43 * 
Adiponectin (mg/L) 11.61 ± 5.45 12.90 ± 5.74 10.29 ± 4.79 * 
Complement C3 (g/L) 1.17 ± 0.16 1.18 ± 0.16 1.17 ± 0.16 
Complement C4 (g/L) 0.21 ± 0.06 0.21 ± 0.06 0.21 ± 0.06 
ESR (mm/h) 6.22 ± 6.15 7.44 ± 6.47 4.98 ± 5.53 * 
Leptin (ng/mL) 4.12 ± 4.93 6.21 ± 5.6 1.98 ± 2.85 * 
 n (%) n (%) n (%) 
Tanner A    
Stage ≤2 41 (7.8) 8 (3) 33 (12.6) 
Stage 3 171 (32.3) 78 (29.2) 93 (35.5) 
Stage 4 247 (46.7) 145 (54.3) 102 (38.9) 
Stage 5 70 (13.2) 36 (13.5) 34 (13.0) 
Tanner B    
Stage ≤2 37 (7) 6 (2.2) 31 (11.8) 
Stage 3 115 (21.7) 64 (24) 51 (19.5) 
Stage 4 262 (49.5) 125 (46.8) 137 (52.3) 
Stage 5 115 (21.8) 72 (27) 43 (16.4) 
 
p < 0.05 for sex comparisons (two-tailed t-test). 
BF%, body fat percentage; BMI, body mass index (according to the age and sex-specific cut-off values of the International Obesity 
Task Force [IOTF]); CRP, high sensivity C-reactive protein; ESR, erythrocyte sedimentation rate; NW, normal weight; OB, obese; 
OW, overweight; 
SD, standard deviation; Tanner A, breast development in girls, genital development in boys; Tanner B, pubic hair development; 





Table 2. AUC, 95% CI, p values, sensitivity, specificity and cut-off values for the associations of measures of overall 
and abdominal adiposity with inflammatory and metabolic markers for girls. 
 























AUC 0.754a 0.641 0.588 0.708 0.660 0.662 0.913 
95% CI 0.698–0.804 0.580–0.698 0.526–0.648 0.649–0.762 0.600–0.716 0.602–0.718 0.872–0.944 
p value <0.001 0.004 0.101 <0.001 0.004 0.004 <0.001 
Sensitivity 88 74.4 94.3 66.7 87.5 46.7 96.8 
Specificity 57.4 51.8 26.3 70.2 45.1 89.9 71.6 







AUC 0.748 0.660 0.625 0.720 0.677 0.672 0.908 
95% CI 0.692–0.799 0.600–0.717 0.564–0.683 0.662–0.773 0.617–0.732 0.612–0.728 0.866–0.940 
p value <0.001 <0.001 0.019 <0.001 0.001 0.002 <0.001 
Sensitivity 92 62.8 94.3 51.3 81.2 56.7 87.1 
Specificity 51.7 67.4 28 85.1 54 79.7 80.1 



























AUC 0.716 0.658 0.602 0.698 0.634 0.663 0.872 
95% CI 0.657–0.769 0.598–0.715 0.540–0.661 0.639–0.753 0.573–0.691 0.603–0.720 0.826–0.910 
p value <0.001 0.001 0.057 <0.001 0.016 0.004 <0.001 
Sensitivity 68 41.9 82.9 51.3 90.6 50 87.1 
Specificity 74.4 83.9 34.5 85.1 35.3 83.1 75.4 





AUC 0.757 0.666 0.598 0.700 0.619 0.700 0.880 
95% CI 0.701–0.807 0.606–0.722 0.536–0.657 0.641–0.754 0.558–0.678 0.641–0.754 0.835–0.916 
p value <0.001 <0.001 0.068 <0.001 0.033 <0.001 <0.001 
Sensitivity 84 72.1 45.7 56.4 68.7 60 93.5 
Specificity 65.3 56.7 73.7 80.3 52.3 78.1 67.8 





AUC 0.748 0.663 0.604 0.710 0.616 0.675 0.850 
95% CI 0.691–0.799 0.603–720 0.499–0.622 0.651–0.763 0.555–0.675 0.616–0.731 0.801–0.891 
p value <0.001 <0.001 0.051 <0.001 0.037 0.002 <0.001 
Sensitivity 76 76.7 51.4 66.7 50 53.3 64.5 
Specificity 74 50.4 73.3 76.3 71.9 80.6 90.3 
Cut-off ≥0.88 ≥0.83 ≥0.89 ≥0.89 ≥0.88 ≥0.92 ≥0.97 
 
AUC, area under the curve; CI, confidence interval, BF%, body fat percentage; BMI, body mass index; CRP, C-reactive protein; ESR, 
erythrocyte sedimentation rate; WC, waist circumference; WHtR, waist-to-height ratio; WsHtR, waist-to-sitting-height ratio. 
a Values in bold represent the ROC curves indicating the adiposity measures that presented the higher AUC for each biomarker. 








Table 3. AUC, 95% CI, p values, sensitivity, specificity and cut-off values for the associations of measures of overall 1 
and abdominal adiposity with inflammatory and metabolic markers for boys. 2 
 3 

























AUC 0.590 0.608 0.534 0.688 0.565 0.560 0.929a 
95% CI 0.527–0.650 0.546–0.668 0.472–0.596 0.628–0.743 0.502–0.626 0.498–0.621 0.890–0.957 
p value 0.15 0.029 0.587 <0.001 0.21 0.29 <0.001 
Sensitivity 76 73.8 83.3 48.9 70.3 26.7 97.1 
Specificity 48.1 46.8 39.1 82.9 48.9 95.3 79.8 







AUC 0.558 0.613 0.574 0.689 0.566 0.600 0.911 
95% CI 0.496–0.619 0.551–0.673 0.511–0.634 0.629–0.745 0.504–0.627 0.538–0.660 0.869–0.942 
p value 0.349 0.022 0.246 <0.001 0.20 0.08 <0.001 
Sensitivity 24 50 58.3 60 27 46.7 91.2 
Specificity 94.5 71.8 61.3 73.7 94.2 78 84.2 



























AUC 0.630 0.629 0.544 0.693 0.584 0.593 0.900 
95% CI 0.568–0.688 0.568–0.688 0.482–0.606 0.634–0.749 0.521–0.644 0.530–0.653 0.858–0.934 
p value 0.038 0.009 0.482 <0.001 0.11 0.10 <0.001 
Sensitivity 64 57.1 75 44.4 32.4 40 91.2 
Specificity 60.3 63.2 39.5 87.1 83.1 83.6 77.6 





AUC 0.604 0.592 0.546 0.689 0.554 0.587 0.911 
95% CI 0.542–0.664 0.530–0.652 0.484–0.607 0.629–0.744 0.492–0.615 0.525–0.648 0.870–0.943 
p value 0.095 0.062 0.465 <0.001 0.30 0.129 <0.001 
Sensitivity 52 33.3 45.8 48.9 29.7 36.7 91.2 
Specificity 66.7 87.3 66 82.9 92.4 89.2 80.7 





AUC 0.603 0.624 0.561 0.691 0.567 0.608 0.896 
95% CI 0.541–0.663 0.563–0.683 0.543–0.663 0.631–0.746 0.503–0.627 0.547–0.668 0.853–0.931 
p value 0.09 0.012 0.33 <0.001 0.20 0.059 <0.001 
Sensitivity 44 66.7 83.3 46.7 27 36.7 88.2 
Specificity 75.5 59.1 34.5 87.1 94.6 86.6 82 
Cut-off ≥0.92 ≥0.86 ≥0.81 ≥0.95 ≥1.04 ≥0.96 ≥0.92 
 4 
AUC, area under the curve; CI, confidence interval, BF%, body fat percentage; BMI, body mass index; CRP, C-reactive protein; ESR, 5 
erythrocyte sedimentation rate; WC, waist circumference; WHtR, waist-to-height ratio; WsHtR, waist-to-sitting-height ratio. 6 
a Values in bold represent the ROC curves indicating the adiposity measures that presented the higher AUC for each biomarker. 7 
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